I-mab Biopharma Us Limited
Clinical trials sponsored by I-mab Biopharma Us Limited, explained in plain language.
-
New drug trial hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called TJ033721 (givastomig) in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 330 partici…
Phase: PHASE1 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 26, 2026 10:24 UTC
-
New drug combo aims to fight tough stomach and esophageal cancers
Disease control Recruiting nowThis study tests whether adding the experimental drug givastomig to standard immunotherapy and chemotherapy helps people with advanced stomach or esophageal cancer live longer without their cancer growing. About 180 adults whose tumors have certain proteins (CLDN18.2 and PD-L1) w…
Phase: PHASE2 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 18, 2026 12:08 UTC